HomeProductsBioactive CompoundsAnti-Infective AgentsHBVViramidine
Chemical structure of CAS 119567-79-2

Viramidine

CAS No.119567-79-2
MDL No.N/A
MFC8H13N5O4
MW243.22
InChI KeyNHKZSTHOYNWEEZ-AFCXAGJDSA-N

Pricing & Availability

Pack SizePurityPriceAvailabilityAction
- -On RequestOn Request
Custom synthesis and bulk supply options are available upon request.

Product Information

Taribavirin is a nucleobase-containing molecule.

CAS No.119567-79-2
Product NameViramidine

Associated Conditions

chronic hepatitis C virus infection
* The information provided here is compiled from public sources and is for reference only.

Related Articles

Studies related to this compound and its mechanism of action

A phase III study of the safety and efficacy of viramidine versus ribavirin in treatment-naïve patients with chronic hepatitis C: ViSER1 results.

Hepatology (Baltimore, Md.) • Vol. 50, Issue 3 • 2009
PMID: 19585653DOI: 10.1002/hep.23073

Taribavirin for the treatment of chronic hepatitis C.

Expert opinion on pharmacotherapy • Vol. 9, Issue 18 • 2008
PMID: 19040344DOI: 10.1517/14656560802594459

Virological response and safety outcomes in therapy-nai ve patients treated for chronic hepatitis C with taribavirin or ribavirin in combination with pegylated interferon alfa-2a: a randomized, phase 2 study.

Journal of hepatology • Vol. 47, Issue 1 • 2007
PMID: 17470380DOI: 10.1016/j.jhep.2007.02.018

Emerging strategies for pegylated interferon combination therapy.

Nature clinical practice. Gastroenterology & hepatology • Vol. 4 Suppl 1 • 2007
PMID: 17235281DOI: 10.1038/ncpgasthep0691

Documentation

Similar Products